Advertisement

Journal of Population Ageing

, Volume 8, Issue 1–2, pp 101–112 | Cite as

Future Monetary Costs of Dementia in the United States Under Alternative Dementia Prevalence Scenarios

  • Michael D. HurdEmail author
  • Paco Martorell
  • Kenneth Langa
Article

Abstract

Population aging will likely lead to increases in health care spending and the ability of governments to support entitlement programs such as Medicare and Medicaid. Dementia is a chronic condition that is especially pertinent because of its strong association with old age and because care for dementia is labor intensive and expensive. Indeed, prior research has found that if current dementia prevalence rates persist, population aging will generate very large increases in health care spending for dementia. In this study we considered two alternative assumptions or scenarios about future prevalence. The first adjusts the prevalence projections using recent research that suggests dementia prevalence may be declining. The second uses growth hypertension, obesity and diabetes, and the relationship between dementia and these conditions to adjust future prevalence rates. We find under the first scenario that if the rates of decline in age-specific dementia rates persist, future costs will be much less than previous estimates, about 40 % lower. Under the second scenario, the growth in those conditions makes only small differences in costs.

Keywords

Forecasts of health care costs Dementia 

Notes

Acknowledgments

Research support from the National Institute on Aging under grants R01AG030155 and R01AG041116 is gratefully acknowledged

References

  1. Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurology, 10(9), 819–828.CrossRefGoogle Scholar
  2. Chan, K. Y., Wang, W., Wu, J. J., Liu, L., Theodoratou, E., Car, J., et al. (2013). Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. Lancet, 381(9882), 2016–2023.CrossRefGoogle Scholar
  3. Hurd, M., Martorell, F., Delavande, A., Mullen, K., & Langa, K. M. (2013). The monetary costs of dementia in the United States. New England Journal of Medicine, 368(14), 1326–1334.CrossRefGoogle Scholar
  4. Jorm, A. F. (1994). A short form of the informant questionnaire on cognitive decline in the elderly (IQCODE): development and cross-validation. Psychological Medicine, 24, 145–53 [Erratum, Psychol Med 1995;25:437.].CrossRefGoogle Scholar
  5. Langa, K. M., Larson, E. B., Karlawish, J. H., et al. (2008). Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers & Dementia, 4, 134–144.CrossRefGoogle Scholar
  6. Larson, E. B., Yaffe, K., & Langa, K. M. (2013). New insights into the dementia epidemic. New England Journal of Medicine, 369(24), 2275–2277.CrossRefGoogle Scholar
  7. Manton, K. C., Gu, X. L., & Ukraintseva, S. V. (2005). Declining prevalence of dementia in the U.S. elderly population. Advances in Gerontology, 16, 30–37.Google Scholar
  8. Matthews, F., Arthur, A., Barnes, L. E., Bond, J., et al. (2013). Lancet, 382, 1405–12.CrossRefGoogle Scholar
  9. Plassman, B. L., et al. (2007). Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology, 29(1–2), 125–132.CrossRefGoogle Scholar
  10. Plassman, B. L., et al. (2008). Prevalence of cognitive impairment without dementia in the United States. Annals of Internal Medicine, 148(6), 427–434.CrossRefGoogle Scholar
  11. Prince, M., Guerchet, M., & Prina, M. (2013). Alzheimer’s disease international. Policy brief for heads of government: The global impact of dementia 2013–2050. London: Alzheimer’s Disease International.Google Scholar
  12. Rocca, W. A., Petersen, R. C., Knopman, D. S., Hebert, L. E., Evans, D. A., Hall, K. S., et al. (2011). Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement, 7(1), 80–93.CrossRefGoogle Scholar
  13. Schrijvers, E. M. C., Verhaaren, B. F. J., Koudstaal, P. J., Hofman, A., Ikram, M. A., & Breteler, M. B. B. (2012). Is dementia incidence declining? trends in dementia incidence since 1990 in the Rotterdam Study. Neurology, 78(19), 1456–1463.CrossRefGoogle Scholar
  14. Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurology, 11(11), 1006–1012.CrossRefGoogle Scholar
  15. Wilson, R., Weir, D., Leurgans, S., Evans, D., Hebert, L., Langa, K. M., Plassman, B., Small, B., & Bennett, D. (2011). Sources of variability in estimates of the prevalence of Alzheimer’s disease in the United States. Alzheimer’s and Dementia, 7(1), 74–79.CrossRefGoogle Scholar
  16. Wimo, A., Jönsson, L., Bond, J., Prince, M., & Winblad, B. (2013). Alzheimer disease international. the worldwide economic impact of dementia 2010. Alzheimers & Dementia, 9(1), 1–11.CrossRefGoogle Scholar
  17. Wu, Y. T., Lee, H. Y., Norton, S., Chen, C., Chen, H., He, C., et al. (2013). Prevalence studies of dementia in mainland china, Hong Kong and Taiwan: a systematic review and meta-analysis. PLoS One, 8(6), e66252.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Michael D. Hurd
    • 1
    • 4
    Email author
  • Paco Martorell
    • 2
  • Kenneth Langa
    • 3
  1. 1.RANDSanta MonicaUSA
  2. 2.University of California, Davis, CA and RANDSanta MonicaUSA
  3. 3.University of MichiganAnn ArborUSA
  4. 4.NBERCambridgeUSA

Personalised recommendations